Eric Pansick's questions to Sonoma Pharmaceuticals (SNOA) leadership • Q1 2019
Question
Private Investor Eric Pansick questioned the strength of the quarterly 'bounce back' and asked what concrete steps management is taking, outside of operations, to support the stock price and fulfill their duty to shareholders, citing concerns about executive compensation and potential dilution.
Answer
CFO Robert Miller outlined plans for active participation in upcoming investor conferences and issuing meaningful press releases to improve communication. CEO James Schutz clarified that his and the CFO's compensation is $250,000 annually and that they align with shareholders by purchasing stock. He stressed their commitment to issuing only material press releases. Mr. Miller reiterated that increasing shareholder value is a primary goal through both execution and communication.